Which manufacturers produce generic versions of Mobotinib? What's the latest price?

Mobocertinib (Mobocertinib), a kinase inhibitor targeting epidermal growth factor receptor (EGFR) exon 20 insertion mutations, brings new treatment hope to adult patients with locally advanced or metastatic non-small cell lung cancer. Mobotinib is certainly a treatment option worth considering for patients whose disease continues to progress during or after platinum-based chemotherapy. As the patent period of this drug expires, its generic versions are gradually launched on the market, providing patients with more treatment options.

So, who are the current manufacturers of generic drugs of Mobotinib? In the Laos market, Lucius Pharmaceuticals and Daxiong Pharmaceuticals are the two main manufacturers of generic drugs of Mobotinib. The version produced by Lucius Pharmaceuticals is 40mg*120 tablets, and its price is maintained at more than 3,000 yuan. This price is relatively close to the people, allowing more patients to have access to this innovative drug. Daxiong Pharmaceutical provides another specification choice, its version is 40mg*112 capsules, and the price is also about more than 3,000 yuan, providing patients with more choices.

In addition, in the Bangladeshi market, there is also a generic version of Mobotinib produced by Ziska Pharmaceuticals. The specification of this version is40mg*60 capsules, and the price is about more than 2,000 yuan. Although the price is slightly higher than the version in the Laos market, it still has a significant price advantage compared with the original drug. When patients choose, they can choose the specifications and prices that best suit them based on their condition, medication needs, and financial status.

However, it is worth noting that the selling price of overseas drugs is often affected by a variety of factors, among which exchange rate fluctuations are a factor that cannot be ignored. Therefore, the above-mentioned price information of generic drugs of Mobotinib can only be used as a reference, and the specific price needs to be determined based on the exchange rate and market conditions at the time of purchase.

So, how can patients ensure the quality and reliable source of the drug when purchasing generic versions of Mobotinib? First of all, it is recommended to choose formal channels with good reputation and credibility to purchase. Secondly, understand the qualifications of relevant manufacturers before purchasing to ensure that the medicine is reliable. Finally, after receiving the medicine, the patient should carefully check the packaging, labeling and quality of the medicine itself. If there are any questions or abnormalities, the patient should contact the seller or relevant agency in a timely manner.

To sum up, there are many manufacturers of generic drugs of Mobotinib, and the prices are relatively affordable, providing patients with more treatment options. However, patients still need to be cautious when purchasing and ensure that the source of the medicine they choose is reliable and the quality is guaranteed.

References:

https://www.rxlist.com/exkivity-drug.htm